PJT:NYSEPJT Partners Inc. Analysis

PJT is trading at $152.7, just above its 20‑day SMA of $150.4 and comfortably above the 50‑day SMA of $145.6, while still below the 200‑day SMA of $168.2, indicating a short‑term bounce within a longer‑term downtrend. The stock sits near the lower end of its recent range, with a clear support level at $134.8 and resistance at $165.6, and technical momentum is modestly bullish as the MACD line ($3.73) sits above its signal ($3.53) with a small positive histogram. The RSI of 54 suggests the stock is neither overbought nor oversold, and the beta of roughly 1.1 points to slightly higher volatility than the market, which is confirmed by a 30‑day volatility of nearly 25% and a historic max drawdown of over 30%. Fundamentally, PJT’s trailing P/E of 22.9 exceeds the industry average of 17.3, its price‑to‑book of 12.0 is high, and the DCF fair‑value estimate of $206.3 implies a modest upside of about 4%, while the forward P/E of 18.1 signals improving earnings expectations. The company generates strong margins (gross 95%, operating 23%) and a robust ROE of 32%, with a low payout ratio of 15% supporting dividend sustainability.
Recent analyst sentiment has shifted positively, highlighted by Goldman Sachs upgrading PJT to a Buy with a $170 target, lifting the median price target to $162 and reinforcing the modest upside narrative. The consensus recommendation remains a Hold, but the combination of bullish technical cues, a sustainable dividend, and an upgrade from a major bank suggests a buying opportunity for medium‑ to long‑term investors seeking exposure to high‑margin advisory services.